Elena Puerta Ruiz de Azua-rekin lankidetzan egindako argitalpenak (6)

2009

  1. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine 3,4-methylenedioxymethamphetamine-induced 5-HT toxicity in the rat: XXX Congreso Nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 7, Núm. 1, pp. 71-73

  2. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine- induced 5-HT deficits in the rat

    Journal of Neurochemistry, Vol. 108, Núm. 3, pp. 755-766

2008

  1. Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: Role of mitochondrial ATP-sensitive potassium channels, Akt and ERK

    Journal of Neurochemistry, Vol. 104, Núm. 4, pp. 914-925

  2. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats

    Neuropharmacology, Vol. 54, Núm. 5, pp. 885-900

  3. The relationship between core body temperature and 3,4- methylenedioxymethamphetamine metabolism in rats: Implications for neurotoxicity

    Psychopharmacology, Vol. 197, Núm. 2, pp. 263-278

2007

  1. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats

    European Journal of Pharmacology, Vol. 562, Núm. 3, pp. 198-207